Maria Novisedlakova
Bratislava, BL 84108, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic and predictive significance of inflammatory markers in patients with locally advanced unresectable and metastatic pancreatic cancer treated with first-line chemotherapy FOLFIRINOX or Gemcitabine/Nabpaclitaxel.
Journal: Bratislavske lekarske listy
Published: November 02, 2024
New trends in criteria indicative of neoadjuvant oncological therapy of lower and middle rectal cancers.
Journal: Bratislavske lekarske listy
Published: May 23, 2023
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.
Journal: Frontiers in oncology
Published: February 17, 2023
DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines.
Journal: International journal of molecular sciences
Published: January 01, 2022
Squamous cell rectal cancer in a young woman.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: March 04, 2021
The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
Journal: Biomedicines
Published: November 09, 2020
MRI‑based neoadjuvant therapy indication in middle and low rectal cancer.
Journal: Bratislavske lekarske listy
Published: September 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026